103877-38-9 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 3-(cyclopropylamino)-2-(2,4-dichloro-3-methylbenzoyl)acrylate is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with unique therapeutic properties. Its complex structure allows for the creation of molecules with specific biological activities, potentially leading to the discovery of novel treatments for a range of diseases.
Used in Agrochemical Industry:
In the agrochemical sector, ethyl 3-(cyclopropylamino)-2-(2,4-dichloro-3-methylbenzoyl)acrylate is utilized as a precursor in the production of pesticides and other crop protection agents. Its chemical versatility enables the design of compounds with targeted pest control capabilities, enhancing agricultural productivity and crop protection.
It is crucial to handle ethyl 3-(cyclopropylamino)-2-(2,4-dichloro-3-methylbenzoyl)acrylate with care due to its potential health and environmental hazards, ensuring safe practices in its application and synthesis processes.
Check Digit Verification of cas no
The CAS Registry Mumber 103877-38-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,8,7 and 7 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 103877-38:
(8*1)+(7*0)+(6*3)+(5*8)+(4*7)+(3*7)+(2*3)+(1*8)=129
129 % 10 = 9
So 103877-38-9 is a valid CAS Registry Number.
103877-38-9Relevant academic research and scientific papers
CRYSTALLINE FORM OF OZENOXACIN AND PROCESSES FOR PREPARATION THEREOF
-
Page/Page column 14, (2020/05/12)
The present invention relates to a crystalline form of 1-cyclopropyl-8-methyl-7- (5-methyl-6-(methylamino)pyridin-3-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid the compound of formula-1, which is represented by the following structural formula-1. The
Preparation method of Ozenoxacin and intermediates thereof
-
Paragraph 0097; 0105; 0106; 0107, (2019/01/05)
The invention provides compounds represented by the formula (IIIb) and a preparation method thereof. The invention also provides an application of the compound represented by the formula (IIIb) as a key intermediate in Ozenoxacin preparation.
